Immune Modulators for Treating COVID-19
Clinical trial NCT04593940 · COMPLETED
Trial details
- NCT number
- NCT04593940
- Sponsor
- Daniel Benjamin
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2022-01-30
- Enrollment
- 1971
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.